Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Avanafil on Spermatogenesis
NCT01768676Phase 4Completed
- Sponsor
- VIVUS
- Start
- Dec 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in erectile dysfunction (ED) comparing Avanafil with Placebo (2 arms). Primary endpoint: Percentage of Subjects With a Greater Than or Equal to 50% Decrease in Sperm Concentration From Baseline to Week 26. Started Dec 2012; status: completed.
02
Drugs
avanafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT01768676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01768676.